Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions

International Journal of Gynecological Pathology

Volumn 24, Issue 3, 2005, Pages 265-270

  Briese, Juliane ^a   Sudahl, Solveig ^a   Schulte, Heinrich M ^b   Löning, Thomas ^a   Bamberger, Ana Maria ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ENDOKRINOLOGIKUM HAMBURG   (Germany)

Author keywords

Activating protein 1; Choriocarcinoma; Hydatidiform mole

Indexed keywords

POLYCLONAL ANTIBODY; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTROPHOBLAST; ENDOCRINE FUNCTION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST; TROPHOBLASTIC DISEASE;

FEMALE; GENE EXPRESSION; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTOR AP-1;

EID: 21244457229     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000163023.49965.10     Document Type: Article

References (24)

1. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-6.
2. Angel P, Karin M. The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1991;72:129-57.
3. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001;20:2390-400.
4. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002;4:131-6.
5. Behrens A, Sibilia M, Wagner EF. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 1999;21:326-9.
6. Ozanne BW, McGarry L, Spence HJ, et al. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur J Cancer 2000;36:1640-8.
7. Tulchinsky E. Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol 2000;15:91-128.
8. Philips A, Teyssier C, Galtier F, et al. Fra-1 Expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol 1998;12:973-85.
9. Bamberger AM, Bamberger CM. Placenta. In: Livolsi VA, Asa SL, eds. Endocrine Pathology. New York: Churchill Livingstone, 2000: 351-60.
10. Chimenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001;6:533-42.
11. Bamberger AM, Milde-Langosch K, Rössing E, et al. Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 2001;127:545-50.
12. Bamberger AM, Bamberger CM, Aupers S, et al. Expression pattern of the activating protein-1 family of transcription factors in the human placenta. Mol Hum Reprod 2004;10:223-8.
13. Suzuki T, Okuno H, Yoshida T, et al. Difference in transcriptional regulatory function between c-fos and fra-2. Nucleic Acids Res 1991;19:5537-42.
14. Welter JF, Eckert RL. Differential expression of the fos and jun family members c-fos, fosB, fra-1, fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene 1995;11:2681-7.
15. Bamberger AM, Methner C, Lisboa BW, et al. Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. Int J Cancer 1999;84:533-8.
16. Bamberger AM, Aupers S, Milde-Langosch K, Löning T. Expression pattern of the cell Cycle promoter cyclin E in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67. Int J Gynecol Pathol 2003;22:156-61.
17. Frank HG, Kaufmann P. Nonvillous parts and trophoblast invasion. In: Benirschke K, Kaufmann P, eds. Pathology of the Human Placenta. New York: Springer, 2000:171-272.
18. Morrish DW, Dakour J, Li H. Functional regulation of human trophoblast differentiation. J Reprod Immunol 1998;39:179-95.
19. Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J Clin Invest 1997;99:2139-51.
20. Soper JT, Clarke-Pearson D, Hammond CB. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients. Obstet Gynecol 1988;71:338-43.
21. Seckl MJ, Fisher RA, Salerno G, et al. Choriocarcinoma and partial hydatidiform moles. Lancet 2000;356:36-9.
22. Schreiber M, Wang ZQ, Jochum W, et al. Placental vascularisation requires the AP-1 component Frau-1. Development 2000;127:4937-48.
23. Fulop V, Mok SC, Gati I, et al. Recent advances in molecular biology of gestational trophoblastic diseases. J Reprod Med 2002;47:369-79.
24. Bamberger AM, Sudahl S, Löning T, et al. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions. Am J Pathol 2000;156:1165-70.